E Alejandro Sweet-Cordero Selected Research

cardiotrophin-like cytokine

1/2020	Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.
11/2019	Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Alejandro Sweet-Cordero Research Topics

Disease

27	Neoplasms (Cancer) 09/2022 - 04/2010
5	Lung Neoplasms (Lung Cancer) 01/2018 - 04/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2013 - 04/2010
4	Osteosarcoma (Osteogenic Sarcoma) 09/2022 - 01/2019
4	Adenocarcinoma of Lung 01/2021 - 01/2016
2	Carcinogenesis 01/2020 - 12/2014
2	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2017
2	Ewing Sarcoma (Sarcoma, Ewing) 05/2017 - 12/2014
2	Genetic Translocation (Chromosomal Translocation) 05/2017 - 12/2014
2	Residual Neoplasm 02/2013 - 01/2012
1	Infections 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Neuroblastoma 01/2020
1	Osteoporosis 01/2020
1	Atherosclerosis 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2019
1	Teratoma (Teratoid Tumor) 10/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 07/2017
1	Adenocarcinoma 10/2015
1	Wilms Tumor (Wilm's Tumor) 11/2010

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
4	Transcription Factors (Transcription Factor)IBA 01/2017 - 11/2010
2	Pharmaceutical PreparationsIBA 09/2022 - 06/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 05/2013
2	LigandsIBA 01/2020 - 02/2013
2	cardiotrophin-like cytokineIBA 01/2020 - 11/2019
2	RNA (Ribonucleic Acid)IBA 10/2019 - 10/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 04/2010
2	PlatinumIBA 01/2018 - 04/2010
2	EWS-FLI fusion proteinIBA 05/2017 - 12/2014
1	MineralsIBA 09/2022
1	Biocompatible Materials (Biomaterials)IBA 09/2022
1	Durapatite (Hydroxylapatite)IBA 09/2022
1	Circulating Tumor DNAIBA 10/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	ras ProteinsIBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2019
1	CytokinesIBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	Biological ProductsIBA 10/2019
1	AsparagineIBA 01/2018
1	Activins (Activin)IBA 01/2018
1	butachlor (Machete)IBA 07/2017
1	Phosphotransferases (Kinase)IBA 03/2017
1	Janus KinasesIBA 03/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2015
1	Long Noncoding RNAIBA 12/2014
1	RNA-Binding Protein EWSIBA 12/2014
1	AgarIBA 12/2014
1	Notch ReceptorsIBA 07/2013
1	Insulin-Like PeptidesIBA 05/2013
1	Glutamine (L-Glutamine)FDA Link 04/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2013
1	ErbB Receptors (EGF Receptor)IBA 02/2013
1	Interleukin-6 (Interleukin 6)IBA 11/2012

Therapy/Procedure

14	Therapeutics 06/2022 - 04/2010
5	Drug Therapy (Chemotherapy) 01/2019 - 04/2010
1	Precision Medicine 10/2019
1	Heterologous Transplantation (Xenotransplantation) 05/2014
1	Transplantation 07/2013